Cargando…
Immunotherapy for Breast Cancer: First FDA Approved Regimen
1 in 8 women will be affected by breast cancer, which is the most diagnosed malignancy among women. Although breast cancer was regarded as “immunologically cold”, recent studies demonstrate that immunotherapy can be successful employed in combination regimens for the treatment of triple negative bre...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Applied Systems srl
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086078/ https://www.ncbi.nlm.nih.gov/pubmed/32309609 http://dx.doi.org/10.15190/d.2019.4 |